Founded in 2015, Vamsi Pharma Pvt. Ltd. has established itself as a trusted partner in the pharmaceutical industry, specializing in the development and manufacturing of orally inhaled & nasal drug products (OINDP). Over the years, we have grown into a dual-role organization—functioning both as a Contract Research Organization (CRO) and a Contract Development and Manufacturing Organization (CDMO)—with a sharp focus on delivering inhalation therapies that improve patient outcomes across the globe.
Our WHO-GMP certified facility, located in Hyderabad Telangana, India, is dedicated to advancing inhalation technology with a special emphasis on Dry Powder Inhalers (DPI). From premix development to formulations and device combination products, we provide comprehensive services tailored to meet the diverse needs of pharmaceutical partners.
At Vamsi Pharma, we believe in offer our unique “Concept to Commissioning” model. This approach ensures that every stage of product development—from ideation, research, and formulation to regulatory compliance, scale-up, and market launch—is handled with precision, speed, and cost-effectiveness. We are committed to helping our partners bring innovative, high-quality inhalation products to market faster while maintaining the highest standards of compliance and patient safety.